Psychiatry and Neurology, Neurology · Portland, OR
NPI
1326200163
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3303 SW Bond Ave Ste 8
Portland, OR, 97239
Phone (503) 494-7772
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
641 services
Medicare patients, 2024
263
Average age 70
Drug cost, 2024
$3.9M
399 prescriptions
Company payments, 2025
$162K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chafic Karam was code 95886 (electrical nerve conductivity), 93 times for 69 patients. In total Chafic Karam billed 641 services in 29 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-01-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95886 Electrical Nerve Conductivity | Facility | 93 | 69 | $35.59 | $3,310 |
| 99214 Office E&M - Established | Facility | 90 | 76 | $72.42 | $6,518 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 75 | 66 | $13.33 | $1,000 |
| 95923 Electrical Nerve Conductivity | Facility | 41 | 41 | $33.10 | $1,357 |
| 95924 Electrical Nerve Conductivity | Facility | 41 | 41 | $66.06 | $2,709 |
| 99215 Office E&M - Established | Facility | 41 | 37 | $116.92 | $4,794 |
| 95885 Electrical Nerve Conductivity | Facility | 35 | 22 | $14.63 | $512 |
| 99204 Office E&M - New | Facility | 31 | 31 | $85.59 | $2,653 |
| 95937 Electrical Nerve Conductivity | Facility | 30 | 15 | $27.38 | $821 |
| 95911 Electrical Nerve Conductivity | Facility | 29 | 29 | $101.48 | $2,943 |
| 95913 Electrical Nerve Conductivity | Facility | 21 | 21 | $144.32 | $3,031 |
| 95910 Electrical Nerve Conductivity | Facility | 16 | 16 | $83.72 | $1,340 |
| 99205 Office E&M - New | Facility | 15 | 15 | $138.30 | $2,075 |
| 95912 Electrical Nerve Conductivity | Facility | 13 | 13 | $115.55 | $1,502 |
| 95872 Electrical Nerve Conductivity | Facility | 12 | 12 | $118.22 | $1,419 |
By year: 2022 $38K for 525 services; 2023 $43K for 608 services; 2024 $40K for 641 services.
Medicare prescription drug claims, 2024
In 2024, the drug Chafic Karam prescribed most often to Medicare patients was Gabapentin, with 74 prescriptions and refills. In total Chafic Karam wrote 399 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 74 | 132 | 22 | $2,236 |
| Duloxetine Hcl Generic | 26 | 46 | Under 11 | $305 |
| Wainua Eplontersen Sodium | 21 | 21 | Under 11 | $876K |
| Sodium Chloride 0.9 % Sodium Chloride | 20 | 20 | Under 11 | $34.63 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 19 | 19 | Under 11 | $272K |
| Nortriptyline Hcl Generic | 19 | 57 | Under 11 | $437 |
| Onpattro Patisiran Sodium,lipid Complex | 17 | 17 | Under 11 | $485K |
| Famotidine Famotidine/Pf | 16 | 16 | Under 11 | $17.12 |
| Dexamethasone Generic | 16 | 16 | Under 11 | $19.63 |
| Mycophenolate Mofetil Generic | 14 | 22 | Under 11 | $514 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 13 | 13 | Under 11 | $328K |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 12 | 12 | Under 11 | $300K |
| Amvuttra Vutrisiran Sodium | 11 | 33 | Under 11 | $1.2M |
Brand drugs: 134 claims; generic drugs: 265 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chafic Karam $162K ($162K in general payments such as food, travel and fees) from 14 companies. The largest payer was Argenx US, Inc. with $70K.
| Company | Payments | Amount |
|---|---|---|
| Argenx US, Inc. ARGX | 29 | $70K |
| Sanofi US Services Inc. SNY | 3 | $31K |
| Genzyme Corporation SNY | 6 | $24K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 28 | $19K |
| Vertex Pharmaceuticals Incorporated VRTX | 14 | $7,691 |
| AstraZeneca UK Limited AZN | 1 | $3,491 |
| Janssen Biotech, Inc. JNJ | 3 | $3,440 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 1 | $2,000 |
| Catalyst Pharmaceuticals, Inc. CPRX | 2 | $1,370 |
| Amgen Inc. AMGN | 1 | $1,200 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.